AMANDA DAVENPORT: Open Payments
NPI 1174018857 · FORT OGLETHORPE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,098 in 63 payments from 32 companies in 2025. Trend: 2023 $1,220 · 2024 $1,225 · 2025 $2,098
Food & beverage: $1,898Long term medical supply or device loan: $199
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $378 |
| Galvanize Therapeutics, Inc | 1 | $151 |
| JAZZ PHARMACEUTICALS INC. | 1 | $133 |
| Novocure Inc. | 1 | $129 |
| Regeneron Healthcare Solutions, Inc. | 4 | $123 |
| Astellas Pharma US Inc | 1 | $103 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $92 |
| Janssen Biotech, Inc. | 3 | $79 |
| Gilead Sciences, Inc. | 3 | $72 |
Products named: KISQALI, ALIYA SYSTEM, ZIIHERA, Optune Lua (NovoTTF-200T), Vyloy, LIBTAYO, Trodelvy, CABOMETYX.
Industry payments across GA — which companies pay providers there.
